An intervention to reduce neuropsychiatric symptoms and caregiver burden in dementia: Preliminary results from a randomized trial of the tailored activity program-outpatient version

Carregando...
Imagem de Miniatura
Citações na Scopus
47
Tipo de produção
article
Data de publicação
2019
Editora
WILEY
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v.34, n.9, Special Issue, p.1301-1307, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective To evaluate the efficacy of the tailored activity program-outpatient version (TAP-O) and to reduce neuropsychiatric symptoms (NPS) in patients with dementia and caregiver burden compared with a control group (psychoeducation intervention). Methods Twenty-one persons with dementia and their caregivers were recruited and randomized. The intervention group received TAP-O, designed for outpatients with dementia and their caregivers. TAP-O consisted of eight sessions in which an occupational therapist assessed the patient's abilities and interests; prescribed tailored activities; and educated caregivers about dementia, NPS, and how to implement meaningful activities in the daily routine. The control group received eight sessions of a psychoeducation intervention about dementia and NPS. Results Compared with controls, patients receiving TAP-O had a significant decrease in hallucination (P = 0.04), agitation (P = 0.03), anxiety (P = 0.02), aggression (P = 0.01), sleep disorder (P = 0.02), aberrant motor behavior (P = 0.02), and in caregiver burden (P = 0.003). Conclusions Findings suggest that TAP-O may be an effective nonpharmacological strategy to reduce NPS of outpatients with dementia and to minimize caregiver burden.
Palavras-chave
caregiver burden, dementia, family caregiving, neuropsychiatric behaviors, nonpharmacologic intervention, occupational therapy
Referências
  1. Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39
  2. BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001
  3. Brodaty H, 2012, AM J GERIAT PSYCHIAT, V20, P549, DOI 10.1097/JGP.0b013e31822be242
  4. Burns A, 2011, DEMENT GERIATR COGN, V31, P158, DOI 10.1159/000324438
  5. Cerejeira J, 2012, Front Neurol, V3, P73, DOI 10.3389/fneur.2012.00073
  6. Cohen-Mansfield J, 1998, J GERONTOL A-BIOL, V53, pM65, DOI 10.1093/gerona/53A.1.M65
  7. Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878
  8. Creavin ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011145.pub2
  9. de Medeiros K, 2010, INT PSYCHOGERIATR, V22, P984, DOI 10.1017/S1041610210000876
  10. de Oliveira AM, 2015, BIOMED RES INT, DOI 10.1155/2015/218980
  11. Dowling GA, 2007, WESTERN J NURS RES, V29, P961, DOI 10.1177/0193945907303083
  12. Gauthier S, 2008, INT J GERIATR PSYCH, V23, P537, DOI 10.1002/gps.1949
  13. Gitlin LN, 2008, AM J GERIAT PSYCHIAT, V16, P229, DOI 10.1097/JGP.0b013e318160da72
  14. Gitlin LN, 2018, J AM GERIATR SOC, V66, P339, DOI 10.1111/jgs.15194
  15. Gitlin LN, 2016, CONTEMP CLIN TRIALS, V49, P92, DOI 10.1016/j.cct.2016.06.006
  16. Gitlin LN, 2012, JAMA-J AM MED ASSOC, V308, P2020, DOI 10.1001/jama.2012.36918
  17. Gitlin LN, 2010, AM J GERIAT PSYCHIAT, V18, P510, DOI 10.1097/JGP.0b013e3181c37d13
  18. Gitlin LN, 2009, GERONTOLOGIST, V49, P428, DOI 10.1093/geront/gnp087
  19. Irving J, 2017, INT J AGING HUM DEV
  20. Kales HC, 2007, AM J PSYCHIAT, V164, P1568, DOI 10.1176/appi.ajp.2007.06101710
  21. Kar Nilamadhab, 2009, Indian J Psychiatry, V51 Suppl 1, pS77
  22. Lowery D, 2014, INT J GERIATR PSYCH, V29, P819, DOI 10.1002/gps.4062
  23. Lyketsos Constantine G, 2011, Alzheimers Dement, V7, P532, DOI 10.1016/j.jalz.2011.05.2410
  24. Novelli MMPC, 2018, ALZ DIS ASSOC DIS, V32, P339, DOI 10.1097/WAD.0000000000000256
  25. O'Connor CM, 2014, INT PSYCHOGERIATR, V26, P857, DOI 10.1017/S1041610214000040
  26. O'Connor CM, 2019, DISABIL REHABIL, V41, P299, DOI 10.1080/09638288.2017.1387614
  27. Pires Camargo Novelli MM, 2016, ALZHEIMERS DEMENT, V12, pP988
  28. Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d
  29. Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004
  30. Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749
  31. Sink KM, 2006, J AM GERIATR SOC, V54, P796, DOI 10.1111/j.1532-5415.2006.00697.x
  32. Stella F, 2013, INT PSYCHOGERIATR, V25, P1503, DOI 10.1017/S1041610213000811
  33. Storti LB, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.0580.2751
  34. Svonsdottir HB, 2006, INT PSYCHOGERIATR, V18, P613, DOI 10.1017/S1041610206003206
  35. Taub Anita, 2004, Cad. Saúde Pública, V20, P372, DOI 10.1590/S0102-311X2004000200004
  36. Trahan MA, 2014, HEALTH EDUC BEHAV, V41, p70S, DOI 10.1177/1090198114531782
  37. van der Linde R, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-87
  38. van der Ploeg ES, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-49
  39. ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649